Cost of New Hepatitis Drug Raises Questions About Equal Access
A new treatment for hepatitis C is considered a breakthrough for people with the liver disease. But the high cost of the drug has complicated efforts to get the medication to Texans who receive government-subsidized health care. Full Story
/https://static.texastribune.org/media/images/2014/05/22/Solvaldi.jpg)